The MOVE ON Trial: A Randomized Trial of Gamification and Coaching to Improve Mobility After Hospitalization
NCT: NCT05736484 ·
Status: ACTIVE NOT RECRUITING ·
Phase: N/A
· Sponsor: University of Pennsylvania
· Started: 2023-09-19
· Est. Completion: 2026-07-01
Official Summary
The objective of this study is to test the feasibility of using behavioral economic interventions (gamification with social incentives) to increase physical activity after hospital discharge to reduce incident mobility disability among older adults.
Study Design
- Study Type: INTERVENTIONAL
- Allocation: RANDOMIZED
- Model: PARALLEL
- Masking: TRIPLE
- Enrollment: 350 participants
Interventions
- BEHAVIORAL: Social Support Gamification — Participants sign a pre-commitment contract agreeing to try their best to achieve their daily step goal. Over the 26-week intervention period, participants are endowed 70 points (10/day) weekly and informed they will lose 10 points each day goal is not met. Points are replenished at start of each week. At the end of each week, if the participant has 40 points or more, they will advance a level, or drop a level if they have less than 40 points. The levels include blue (lowest), bronze, silver, go
Primary Outcomes
- Change in mean daily step count from baseline to the end of the 26 week intervention period. (Baseline to 26 week intervention period (Weeks 1-26))
Secondary Outcomes
- Change in mean daily step count from baseline to the end of the 26 week follow-up period. (Baseline to 52 weeks- end of the study (Weeks 1-52))
- Participants' mobility disability throughout the entire study (Baseline to end of study [52 weeks]). (Baseline to 26 and 52 weeks- end of the study (Weeks 1-52))
- Participants' acute care utilization throughout the entire study (Baseline to end of study [52 weeks]). (Baseline to 26 and 52 weeks- end of the study (Weeks 1-52))
Trial Locations
- Blockley Hall, Philadelphia, Pennsylvania, United States
More Hypertension Trials
AI-generated analysis for educational purposes only. This is not medical advice. Discuss clinical trial participation with your doctor. Data sourced from ClinicalTrials.gov.